HERSH KOZLOV - 01 Jul 2022 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
Director
Signature
/s/ Richard S. Nelson as Attorney-in-Fact
Issuer symbol
VTVT
Transactions as of
01 Jul 2022
Net transactions value
$0
Form type
4
Filing time
06 Jul 2022, 16:13:54 UTC
Previous filing
26 May 2022
Next filing
26 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTVT Director stock option (right to buy) Award $0 +105,128 $0.000000 105,128 01 Jul 2022 Class A Common Stock 105,128 $0.7200 Direct F1
holding VTVT Director stock option (right to buy) 26,250 01 Jul 2022 Class A Common Stock 26,250 $2.65 Direct F2, F3
holding VTVT Director stock option (right to buy) 15,000 01 Jul 2022 Class A Common Stock 15,000 $2.54 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 An option to purchase 80,128 shares vested immediately on July 1, 2022. The remaining option to purchase 25,000 shares vests on June 1, 2023.
F2 On June 15, 2020 and May 5, 2021, the reporting person filed Form 4s which inadvertently aggregated options to purchase shares of Class A common stock with different exercise prices and expiration dates. These errors have been corrected in the options beneficially owned in this Form 4.
F3 An option to purchase 2,812 shares vested immediately on June 11, 2020. The remaining option to purchase 23,438 shares vests in equal monthly installments over the three-year period beginning on June 11, 2020.
F4 Vests in equal monthly installments over the three-year period beginning May 3, 2021.